US Stock MarketDetailed Quotes

CWK Cushman & Wakefield

Watchlist
  • 11.890
  • -0.010-0.08%
Close Feb 28 16:00 ET
  • 11.890
  • 0.0000.00%
Post 17:15 ET
2.73BMarket Cap21.23P/E (TTM)

Cushman & Wakefield Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cushman & Wakefield Q4 2024 Earnings Date

Currency：USDFeb 20, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
2.67B
2.63B
-40.32M
Miss Est.
+4.60%
+3.02%
-1.51%
EPS
0.38
0.48
+0.10
Beat Est.
+27.17%
+60.00%
+25.82%
Analyst Rating
Hold

Feb 28, 2025

Cushman & Wakefield Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 2.379B--
--2025/Q1-- / 2.252B--
Feb 20, 20252024/Q42.630B / 2.670B--
Nov 4, 20242024/Q32.344B / 2.386B--
Jul 29, 20242024/Q22.288B / 2.357B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 2.379B--
--2025/Q1-- / 2.252B--
Feb 20, 20252024/Q42.630B / 2.670B--
Nov 4, 20242024/Q32.344B / 2.386B--
Jul 29, 20242024/Q22.288B / 2.357B--

Unlock Free Earnings Estimates

Cushman & Wakefield Earnings Reports

  • Cushman & Wakefield | 10-K: FY2024 Annual Report

    Feb 21 12:58 ET

  • Cushman & Wakefield | 8-K: Cushman & Wakefield Reports Financial Results for the Fourth Quarter and Full Year 2024

    Feb 20 07:06 ET

  • Cushman & Wakefield | 10-Q: Q3 2024 Earnings Report

    Nov 5, 2024 13:06 ET

  • Cushman & Wakefield | 8-K: Cushman & Wakefield Reports Financial Results for the Third Quarter 2024

    Nov 4, 2024 16:13 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Feb 28, 2025

    Hold

    • Buy

      40.00%

    • Hold

      40.00%

    • Sell

      20.00%

    Price Target

    No Data